FULC Fulcrum Therapeutics

Watchlist

Close Apr 26 16:00 ET

Post 16:00 ET

443.78MMarket Cap-4490P/E (TTM)

Fulcrum Therapeutics Stock Analyst Ratings & Price Target

Updated: Apr 25, 2024

Based on 6 analysts giving stock ratings to Fulcrum Therapeutics in the past 3 months

Strong Buy

Updated: Apr 25, 2024

The average Fulcrum Therapeutics stock price target is 14.50 with a max estimate of 17.00 and a min estimate of 11.00

Review Fulcrum Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 25, 2024

Strong Buy

Updated: Apr 25, 2024

Overall